Astera Labs, Inc. Common Stock · Technology
Paid for today, but breaks on a small cut — or only looks over-priced at a 9% discount rate.
At a 20.0% margin the price needs +40.9% 3y revenue CAGR against +75.3% consensus, a cushion of +5.2pt versus a 37.6pt correction cut. The cushion covers a flush but not the 37.6pt bust a high-exposure name must absorb, so it is fragile. Highest capex beta in the batch; the 75% CAGR deserves a large cut.
Breaks if: Wrong if the 37.6pt cut is too harsh (growth holds near 75%) and margin holds at 20%+; worse if margin settles below 20%, which turns the +5.2pt cushion negative.. We re-check this against analyst estimates every evening.
10 years, at a 20% margin (analysts' margin, cut for cash conversion)
+43.8%/yr over 10 years once faded to terminal growth
points off 3-year analyst growth
12 published targets, set before the drop
Linked to AMD, AMZN, GOOGL, META, MSFT, MU, NVDA
Does the profit analysts build their margin on actually arrive as cash? Measured over the last 3 annual statements filed before this test. After stock-based pay, 35% of reported profit arrived as operating cash, so the test cuts the analysts' 38% margin to 19%. That leaves a cushion of +4pt instead of +23pt, and the smaller of the two decides the group. Two or more red flags: this name cannot come out on top, however large its cushion.
How much of reported profit arrived as operating cash. Below 0.8× is a red flag.
Profit not backed by cash, as a share of assets, latest year. Above 10% is a red flag.
Staff paid in shares instead of cash, which flatters margins. Above 10% is a red flag.
Dilution of each share's claim on the business. Above 3% a year is a red flag.
Non-operating gains in the latest year. Above 25% is a red flag.
After capex. Shown for context: heavy investment is not bad earnings, so it is never solved under.
From the priced-in reconstruction of Sep 10, 2026. Its figures use that day's price and free-cash-flow margin, so they can differ from the stress test above.
The price sits at the 17th percentile of published models, 27% below the median, meaning the market has heard the bull case for AI connectivity but refuses to pay for its full upside.
Can Scorpio's platform transition and rising content per accelerator sustain revenue growth above 40% despite extreme customer concentration, and the wired data cannot measure this product mix shift.
What the price refuses to pay for, and the full reconstruction, on the ALAB quote page →A stress test of whether this narrative is still paid for by analyst forecasts, not a forecast that the stock will rise. The price-implied growth on its own has not predicted returns in our testing, and this list (sealed Nov 21, 2026) has not been graded yet. Cut sizes are assumptions. Not investment advice. Back to all names